Francisco Javier Cabello Albendea
Finanzdirektor/CFO bei Biocross SL
Aktive Positionen von Francisco Javier Cabello Albendea
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Private Equity Investor | - | - |
Biocross SL
 Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Finanzdirektor/CFO | - | - |
Karriereverlauf von Francisco Javier Cabello Albendea
Ehemalige bekannte Positionen von Francisco Javier Cabello Albendea
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
DBP Conseil & Management SA
 DBP Conseil & Management SA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., DBP Conseil & Management SA is a management consulting company based in Madrid, Spain. The Spanish company was founded by Francisco Javier Cabello Albendea. DBP Conseil & Management was acquired by PricewaterhouseCoopers LLP on November 17, 2008. | Gründer | - | - |
| Corporate Officer/Principal | - | - | |
| BANCO SANTANDER, S.A. | Corporate Officer/Principal | - | - |
| Roland Berger Strategy Consultants SA | Corporate Officer/Principal | - | - |
Dendrico SL
 Dendrico SL Miscellaneous Commercial ServicesCommercial Services Dendrico SL is a holding company engaged in the development and manufacture of nanotechnology systems. These find applications in the fields of diagnostics, therapeutics, and medical research. The company was founded in 2005 and is headquartered in Madrid, Spain. | Direktor/Vorstandsmitglied | 29.03.2010 | - |
Ausbildung von Francisco Javier Cabello Albendea
| Instituto Catolico de Administracion y Direccion de Empresas | Undergraduate Degree |
| University of Navarra | Masters Business Admin |
Statistik
International
| Spanien | 9 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Private Equity Investor | 1 |
Sektoral
| Commercial Services | 3 |
| Finance | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BANCO SANTANDER, S.A. | Finance |
| Private Unternehmen | 5 |
|---|---|
Dendrico SL
Dendrico SL Miscellaneous Commercial ServicesCommercial Services Dendrico SL is a holding company engaged in the development and manufacture of nanotechnology systems. These find applications in the fields of diagnostics, therapeutics, and medical research. The company was founded in 2005 and is headquartered in Madrid, Spain. | Commercial Services |
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
| Roland Berger Strategy Consultants SA | |
DBP Conseil & Management SA
DBP Conseil & Management SA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., DBP Conseil & Management SA is a management consulting company based in Madrid, Spain. The Spanish company was founded by Francisco Javier Cabello Albendea. DBP Conseil & Management was acquired by PricewaterhouseCoopers LLP on November 17, 2008. | Commercial Services |
Biocross SL
Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Health Technology |
